Start main page content

Research

The division is very active in the field of research, both in supervising undergraduate and postgraduate students, as well as in actively conducting research.

Current research activities / Collaborations:

  • The long-term pulmonary function sequelae of viral infections during infancy - Vaccines and Infectious Diseases Analytics Research Unit / University of Cape Town / University of Szeged.
  • Surveillance of viral infectious pathogens in children - Vaccines and Infectious Diseases Analytics Research Unit.
  • COVID-19 - Various studies.
  • Phase 2, Randomized, Double-Blind, Placebo-Controlled, 2-Part Study to Evaluate EDP-938 Regimens in Subjects Aged 28 Days to 24 Months Infected With Respiratory Syncytial Virus (RSV)
  • Respiratory sequelae in children whose mothers were immunized with the RSV F Vaccine in pregnancy; a vaccine probe study
  • Impact of oral step-down to amoxicillin or co-amoxiclav and of duration of antibiotic therapy on effectiveness, safety and selection of antibiotic resistance in severe childhood community-acquired pneumonia (CAP): a randomised controlled trial
  • Point of care ultrasound (POCUS) for the assessment of children with shock, an exploratory observational study
  • Bronchiectasis in African Children: prevalence, aetiology and clinical outcome - National collaborative study.
  • Investigation of the Cystic Fibrosis lung microbiome of patients attending clinics in the Gauteng province, South Africa - National collaborative study with University of Pretoria.
  • South African Cystic Fibrosis Registry Project - National collaborative study.
  • Pain In Children Study (PICS): A multicenter audit of paediatric pain - National collaborative study.
  • Digital Auscultation and Pulmonary Function Testing Among Rural Bangladeshi Infants - Johns Hopkins University
  • Digital auscultation in PERCH: Associations with radiography and pneumonia mortality in children - Johns Hopkins University

A Randomized, Double-Blind, Parallel Group, Multi-centre, Stratified Study Evaluating the Efficacy and Safety of once daily Fluticasone Furoate/Vilanterol Inhalation Powder compared to once daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants aged 5 to 17 years old (inclusive) Currently Uncontrolled on Inhaled Corticosteroids Protocol No: HZA107116.

Share